E7016 / Eisai - LARVOL DELTA

RETRACTION: LncRNA CCAT2 Promotes the Proliferation and Metastasis of Colorectal Cancer Through Activation of the ERK and Wnt Signaling Pathways by Regulating GNB2 Expression. (PubMed, Cancer Med) - "17 (2024): e70169, https://doi.org/10.1002/cam4.70169...The authors further stated that, upon reviewing the published article, they discovered multiple issues related to image overlap and redundancy. All parties agree that the overlapping and duplicated images constitute a major error in the article and it must be retracted."

Journal • Colorectal Cancer • Oncology • Solid Tumor • CCAT2 • GNB2

Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=12 | Terminated | Sponsor: Eisai Inc. | Completed ➔ Terminated; Strategic decision, which is unrelated to safety

Trial termination • Melanoma • Oncology • Solid Tumor

Myriad: Analyst and Investor Day (Myriad Genetics) - Anticipated launch outside US for solid tumors in 2016/2017

Anticipated launch non-US • Oncology